FNIH Logo
Select Sub Page
Biomarkers Consortium
About Biomarkers Consortium
Programs
Join the Consortium
Leadership and Governance
Accomplishments
Biomarkers Consortium
About Biomarkers Consortium
Programs
Join the Consortium
Leadership and Governance
Accomplishments

Biomarkers Consortium

The Biomarkers Consortium brings together various partners to identify, develop and qualify potential biomarkers to improve drug development and regulatory decision-making. 

Spotlight

Spotlight
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration
Read more
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration
Spotlight
New Video–Vol-PACT: A Novel Cancer Imaging Project
Watch now
https://www.youtube.com/watch?v=Rn6Fe5156C8
Spotlight
Mucosal Healing in Ulcerative Colitis
Learn More
Mucosal Healing

Vision

Improving health through meaningful measurements.

Mission 

To create and lead cross-sector efforts that validate and qualify biomarkers and other drug development tools to accelerate better decision making for the development of new therapeutics and health technologies.